UBS Raises Price Target on MetLife (MET) Following Investor Day

November 11, 2016 9:31 AM EST
Get Alerts MET Hot Sheet
Price: $55.66 --0%

Rating Summary:
    11 Buy, 10 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 26 | Down: 17 | New: 13
Trade MET Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

UBS reiterated a Neutral rating on MetLife (NYSE: MET), and raised the price target to $54.00 (from $48.00), following the company's investor day. Management identified several growth areas including Group benefits, Latin America, and P&C and anticipates its international earnings to grow in proportion. The company also anticipates a near-term ROE spread over risk-free rate of 8%, rising to 9-10% over time. The Board has authorized a $3bn share repurchases program to be completed by the end of 2017.

Analyst Brian Meredith commented, "MET hosted its Investor day this morning, whereby management discussed the strategy, opportunities and challenges. Management identifies several growth areas including Group benefits, Latin America, and P&C and anticipates its international earnings to grow in proportion. It also intends to maximize free cash flow and profitability at MetLife Holdings, while winding down the operation. MET notes all new business require IRR above hurdle rate and short payback period. After separation of Brighthouse (BHF), management estimates an average free cash flow ratio of 65-75% for 2017 and 2018 and continues to target an $800mm net annual savings by 2020."

For an analyst ratings summary and ratings history on MetLife click here. For more ratings news on MetLife click here.

Shares of MetLife closed at $53.74 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Related Entities

UBS, Earnings

Add Your Comment